The TARGIT-A Randomized Trial: TARGIT-IORT Versus Whole Breast Radiation Therapy: Long-Term Local Control and Survival

Affiliations

• ¹ Division of Surgery and Interventional Science, University College London, London, United Kingdom. Electronic address: jayant.vaidya@ucl.ac.uk.
• ² Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Biostatistics, University of Notre Dame, Fremantle, WA, Australia.
• ³ University Medical Centre Freiburg, University of Frieberg, Frieberg, Germany.
• ⁴ Department of Radiation Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
• ⁵ Department of Surgery, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
• ⁶ Department of Surgery, University of California, San Francisco, California.
• ⁷ University College London, London, United Kingdom.
• ⁸ London, United Kingdom.
• ⁹ University of Southern California, John Wayne Cancer Institute & Helen Rey Breast Cancer Foundation, Los Angeles, California.
• ¹⁰ Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
• ¹¹ Department of RadioOncology and Radiotherapy, Technical University of Munich, Munich, Germany.
• ¹² Department of Oncology, St Olav's University Hospital, Trondheim, Norway.
• ¹³ Radiation Oncology, Summit Medical Center, Oakland, California.
• ¹⁴ Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
• ¹⁵ Department of Clinical Oncology, University College London Hospitals, London, United Kingdom.